CLINICAL_TRIALS
trial_result
· 2013-03-11
Clinical Trial Update: Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 study evaluating two dosing regimens of TRU-015 for rheumatoid arthritis was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: TERMINATED | Results posted: 2013-03-11